Table 1.

Traditional control genes across four datasets

Gene Description NC160 AML/ALL Huge index TPA
MFC CV MFC CV MFC CV MFC CV
ACTBActin, beta7.80.393.50.321.30.114.60.35
ALDOAAldolase A8.20.375.70.482.90.372.90.31
G6PDGlucose-6-phosphate dehydrogenase7.70.905.00.4520.284.60.43
GAPDGlyceraldehyde-3-phosphate dehydrogenase5.30.3112.30.3320.191.90.17
B2MBeta-2-microglobulin25.60.5814.00.423.40.274.60.49
PFKPPhosphofructokinase, platelet12.40.68>121.66>960.0814.00.56
PGK1Phosphoglycerate kinase 16.50.446.80.36N/AN/A4.90.41
PGAM1Phosphoglycerate mutase 1 (brain)5.20.4012.40.481.60.193.60.47
TUBA1Tubulin, alpha 1 (testis specific)>501.0953.70.783.10.846.70.46
HPRT1Hypoxanthine phosphoribosyltransferase 1  (Lesch-Nyhan syndrome)10.70.4543.90.531.60.425.60.49
VIMVimentin>3000.6812.70.423.80.4128.90.94
LDHALactate dehydrogenase A91.00.389.20.405.50.604.10.34

[i] CV, coefficient of variation; MFC, maximum fold change; AML/ALL, acute myeloid leukemia/acute lymphoblastic leukemia panels; TPA, phorbol 12-myristate 13-acetate induction.